These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21624004)

  • 1. Pulse steroids as induction therapy for children with ulcerative colitis.
    Kudo T; Nagata S; Ohtani K; Fujii T; Wada M; Haruna H; Shoji H; Ohtsuka Y; Shimizu T; Yamashiro Y
    Pediatr Int; 2011 Dec; 53(6):974-9. PubMed ID: 21624004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral tacrolimus for steroid-dependent and steroid-resistant ulcerative colitis in children.
    Ziring DA; Wu SS; Mow WS; Martín MG; Mehra M; Ament ME
    J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):306-11. PubMed ID: 17873742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of pulse steroid therapy in Japanese pediatric patients with ulcerative colitis: a survey of the Japanese Society for Pediatric Inflammatory Bowel Disease.
    Nagata S; Shimizu T; Kudo T; Tomomasa T; Tajiri H; Yoden A; Kagimoto S; Tahara T; Ushijima K; Uchida K; Kobayashi A
    Digestion; 2010; 81(3):188-92. PubMed ID: 20090334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
    Mantzaris GJ; Sfakianakis M; Archavlis E; Petraki K; Christidou A; Karagiannidis A; Triadaphyllou G
    Am J Gastroenterol; 2004 Jun; 99(6):1122-8. PubMed ID: 15180735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid response in moderate to severe pediatric ulcerative colitis: a single center's experience.
    Cakir M; Ozgenc F; Yusekkaya HA; Ecevit CO; Yagci RV
    World J Pediatr; 2011 Feb; 7(1):50-3. PubMed ID: 21191776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of new-onset ulcerative colitis and ulcerative proctitis: a retrospective study.
    Richter JM; Kushkuley S; Barrett JA; Oster G
    Aliment Pharmacol Ther; 2012 Aug; 36(3):248-56. PubMed ID: 22690748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basiliximab does not increase efficacy of corticosteroids in patients with steroid-refractory ulcerative colitis.
    Sands BE; Sandborn WJ; Creed TJ; Dayan CM; Dhanda AD; Van Assche GA; Greguš M; Sood A; Choudhuri G; Stempien MJ; Levitt D; Probert CS
    Gastroenterology; 2012 Aug; 143(2):356-64.e1. PubMed ID: 22549092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral tacrolimus for pediatric steroid-resistant ulcerative colitis.
    Navas-López VM; Blasco Alonso J; Serrano Nieto MJ; Girón Fernández-Crehuet F; Argos Rodriguez MD; Sierra Salinas C
    J Crohns Colitis; 2014 Jan; 8(1):64-9. PubMed ID: 23582736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
    Miele E; Pascarella F; Giannetti E; Quaglietta L; Baldassano RN; Staiano A
    Am J Gastroenterol; 2009 Feb; 104(2):437-43. PubMed ID: 19174792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to first intravenous steroid therapy determines the subsequent risk of colectomy in ulcerative colitis patients.
    Molnár T; Farkas K; Nyári T; Szepes Z; Nagy F; Wittmann T
    J Gastrointestin Liver Dis; 2011 Dec; 20(4):359-63. PubMed ID: 22187700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early onset steroid-dependent ulcerative colitis is a predictor of azathioprine response: a longitudinal 12-month follow-up study.
    Chebli LA; Felga GG; Chaves LD; Pimentel FF; Guerra DM; Gaburri PD; Zanini A; Chebli JM
    Med Sci Monit; 2010 Feb; 16(2):PI1-6. PubMed ID: 20110928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous infusion versus bolus administration of steroids in severe attacks of ulcerative colitis: a randomized, double-blind trial.
    Bossa F; Fiorella S; Caruso N; Accadia L; Napolitano G; Valvano MR; Andriulli A; Annese V
    Am J Gastroenterol; 2007 Mar; 102(3):601-8. PubMed ID: 17156148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of a conservative approach in severe ulcerative colitis.
    Daperno M; Sostegni R; Scaglione N; Ercole E; Rigazio C; Rocca R; Pera A
    Dig Liver Dis; 2004 Jan; 36(1):21-8. PubMed ID: 14971812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of antibiotic combination therapy in patients with active ulcerative colitis, including refractory or steroid-dependent cases.
    Uehara T; Kato K; Ohkusa T; Sugitani M; Ishii Y; Nemoto N; Moriyama M
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S62-6. PubMed ID: 20586868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab.
    Turner D; Griffiths AM; Veerman G; Johanns J; Damaraju L; Blank M; Hyams J
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1460-5. PubMed ID: 23672831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab for ulcerative colitis in children and adolescents.
    McGinnis JK; Murray KF
    J Clin Gastroenterol; 2008 Sep; 42(8):875-9. PubMed ID: 18645529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic combination therapy for steroid withdrawal in steroid-dependent ulcerative colitis.
    Terao S; Yamashiro K; Tamura I; Hirano T; Ohkusa T; Kato K
    Digestion; 2011; 83(3):198-203. PubMed ID: 21266816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocytapheresis therapy for steroid-naïve patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy.
    Nishioka C; Aoyama N; Maekawa S; Shirasaka D; Nakahara T; Tamura T; Fukagawa M; Umezu M; Abe T; Kasuga M
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1567-71. PubMed ID: 16174075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes and factors for response prediction after the first course of corticosteroid therapy in patients with active ulcerative colitis.
    Yoon JY; Cheon JH; Park JJ; Hong SP; Kim TI; Kim WH
    J Gastroenterol Hepatol; 2011 Jul; 26(7):1114-22. PubMed ID: 21299620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: a randomized, controlled study.
    Bossa F; Latiano A; Rossi L; Magnani M; Palmieri O; Dallapiccola B; Serafini S; Damonte G; De Santo E; Andriulli A; Annese V
    Am J Gastroenterol; 2008 Oct; 103(10):2509-16. PubMed ID: 18721243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.